The effect of medical drug reminder mobile application on treatment compliance in women with breast cancer under adjuvant hormone treatment

Özge Budaycı; Sevgi Özkan

Makale detayları

The effect of medical drug reminder mobile application on treatment compliance in women with breast cancer under adjuvant hormone treatment

Yazarlar:

Özge Budaycı | Sevgi Özkan

Yayıncı:

Pamukkale University

Ana Başlıklar:

Kadın Hastalıkları ve Doğum

Dergi:

Pamukkale Tıp Dergisi Vol.18 Issue 3, pp.592-605

Belge Tipi:

Makale

Yayın Tarihi:

2/2025

Belge Dili:

İngilizce

Document ID (Org No.):

2001329361

pISSN:

1308-0865

Anahtar kelimeler:

Özet:

 Purpose: This study was planned to investigate the effects of a nurse-led medication reminder mobile application on treatment adherence in women with breast cancer receiving adjuvant hormone therapy. Materials and methods: The research was planned as a prospective quasi-experimental study with pretest, posttest, and control groups, in which the simple randomization method was employed. It consisted of 52 women with breast cancer receiving adjuvant hormone therapy, including 26 in the experimental group and 26 in the control group. The medication reminder mobile application developed by the researchers was utilized in the experimental group to determine its effect on treatment adherence. Data collection measures included a personal information form and the Medication Adherence Self-Efficacy Scale MASES. After the baseline data of the experimental and control groups were collected, the experimental group used the Medication Reminder mobile application for eight weeks. At the end of the eight weeks, the MASES was applied to both groups again. Results: A statistically significant difference was found between the pre-test and post-test MASES total scores of the experimental group p0.05. The post-test MASES total scores of the experimental group were significantly higher than their pre-test scores. The inter-group comparisons indicated that the post-test MASES total scores of the experimental group were statistically significantly higher than those of the control group p0.05. Conclusion: It was concluded that the Medication Reminder mobile application was an effective tool in increasing treatment adherence in women with breast cancer under adjuvant hormone therapy.

 Purpose: This study was planned to investigate the effects of a nurse-led medication reminder mobile application on treatment adherence in women with breast cancer receiving adjuvant hormone therapy. Materials and methods: The research was planned as a prospective quasi-experimental study with pretest, posttest, and control groups, in which the simple randomization method was employed. It consisted of 52 women with breast cancer receiving adjuvant hormone therapy, including 26 in the experimental group and 26 in the control group. The medication reminder mobile application developed by the researchers was utilized in the experimental group to determine its effect on treatment adherence. Data collection measures included a personal information form and the Medication Adherence Self-Efficacy Scale MASES. After the baseline data of the experimental and control groups were collected, the experimental group used the Medication Reminder mobile application for eight weeks. At the end of the eight weeks, the MASES was applied to both groups again. Results: A statistically significant difference was found between the pre-test and post-test MASES total scores of the experimental group p0.05. The post-test MASES total scores of the experimental group were significantly higher than their pre-test scores. The inter-group comparisons indicated that the post-test MASES total scores of the experimental group were statistically significantly higher than those of the control group p0.05. Conclusion: It was concluded that the Medication Reminder mobile application was an effective tool in increasing treatment adherence in women with breast cancer under adjuvant hormone therapy.

 Purpose: This study was planned to investigate the effects of a nurse-led medication reminder mobile application on treatment adherence in women with breast cancer receiving adjuvant hormone therapy. Materials and methods: The research was planned as a prospective quasi-experimental study with pretest, posttest, and control groups, in which the simple randomization method was employed. It consisted of 52 women with breast cancer receiving adjuvant hormone therapy, including 26 in the experimental group and 26 in the control group. The medication reminder mobile application developed by the researchers was utilized in the experimental group to determine its effect on treatment adherence. Data collection measures included a personal information form and the Medication Adherence Self-Efficacy Scale MASES. After the baseline data of the experimental and control groups were collected, the experimental group used the Medication Reminder mobile application for eight weeks. At the end of the eight weeks, the MASES was applied to both groups again. Results: A statistically significant difference was found between the pre-test and post-test MASES total scores of the experimental group p0.05. The post-test MASES total scores of the experimental group were significantly higher than their pre-test scores. The inter-group comparisons indicated that the post-test MASES total scores of the experimental group were statistically significantly higher than those of the control group p0.05. Conclusion: It was concluded that the Medication Reminder mobile application was an effective tool in increasing treatment adherence in women with breast cancer under adjuvant hormone therapy.

 Amaç: Bu araştırma, adjuvan hormon tedavisi almakta olan meme kanseri kadınlarda, hemşire öncülüğünde hazırlanmış ilaç hatırlatma mobil uygulamasının tedaviye uyum üzerine etkisinin incelenmesi amacıyla planlanmıştır. Gereç ve yöntemler: Bu araştırma ön test-son test kontrol gruplu, prospektif, basit randomizasyon yöntemi kullanılan, yarı deneysel bir çalışma olarak planlanmış olup, 26 deney ve 26 kontrol grubu olmak üzere toplam 52 adjuvan hormon tedavisi gören meme kanserli kadın ile yürütülmüştür. Araştırmacılar tarafından geliştirilen ilaç alarmı mobil uygulaması deney grubuna tedaviye uyum üzerine etkisini belirlemek amacıyla uygulanmıştır. Verilerin toplanmasında Kişisel Bilgi Formu ve İlaç Tedavisine BağlılıkUyum Öz-Etkililik Ölçeği MASES kullanılmıştır. Deney ve kontrol grubunun ilk verilerinin toplanmasının ardından deney grubu 8 hafta süre ile İlaç Alarmı mobil uygulamasını kullanmıştır. 8 haftalık sürecin sonunda her iki gruba tekrar MASES uygulanmıştır. Bulgular: Deney grubundakilerin ön test  son test MASES toplam puanları arasında istatistiksel olarak anlamlı farklılık saptanmıştır p0,05. Deney grubunun son test MASES toplam puanları ön teste göre anlamlı derecede daha yüksek olduğu tespit edilmiştir. Gruplar arasında ise son test MASES toplam puanları açısından deney grubunun son test toplam puanları istatistiksel olarak anlamlı derece yüksek olduğu saptanmıştır p0,05. Sonuç: Adjuvan hormon tedavisi alan meme kanserli hastalarda İlaç Alarmı mobil uygulamasının tedaviye uyumu arttırma konusunda etkili bir araç olduğu sonucuna ulaşılmıştır.

Makale detayları

The effect of medical drug reminder mobile application on treatment compliance in women with breast cancer under adjuvant hormone treatment

Yazarlar:

Özge Budaycı | Sevgi Özkan

Yayıncı:

Pamukkale University

Ana Başlıklar:

Kadın Hastalıkları ve Doğum

Dergi:

Pamukkale Tıp Dergisi Vol.18 Issue 3, pp.592-605

Belge Tipi:

Makale

Yayın Tarihi:

2/2025

Belge Dili:

İngilizce

Document ID (Org No.):

2001329361

pISSN:

1308-0865

Adjuvant hormone therapy

breast cancer

medication adherence

mobile application

womenAdjuvan hormon tedavisi

ilaç uyumu

meme kanseri

mobil uygulama

kadın

Sayı

Makale detayları

Yazarlar: Özge Budaycı | Sevgi Özkan

Yayıncı: Pamukkale University

Ana Başlıklar: Kadın Hastalıkları ve Doğum

Dergi: Pamukkale Tıp Dergisi Vol.18 Issue 3, pp.592-605

Belge Tipi: Makale

Yayın Tarihi: 2/2025

Belge Dili: İngilizce

Document ID (Org No.): 2001329361

pISSN: 1308-0865

Sayı

Yazarlar:

Özge Budaycı | Sevgi Özkan

Yayıncı:

Pamukkale University

Ana Başlıklar:

Kadın Hastalıkları ve Doğum

Dergi:

Pamukkale Tıp Dergisi Vol.18 Issue 3, pp.592-605

Belge Tipi:

Makale

Yayın Tarihi:

2/2025

Belge Dili:

İngilizce

Document ID (Org No.):

2001329361

pISSN:

1308-0865